[Treatment of asthenic disorders with tanakan].
OBJECTIVE
To evaluate efficacy and safety of tanakan in different asthenic disorders.


METHODS
Tanakan in a dose 240 mg/day was used in 60 patients with various asthenic disorders arising in neurasthenia and late after craniocerebral trauma. The response was assessed by the scale of general clinical impression, side effects and by changes in psychic and somatic status.


RESULTS
The response was achieved in 90% of the patients. 78% had significant improvement regardless nosological entity of asthenia.


CONCLUSIONS
Tanakan is safe and effective in therapy of asthenic disorders. Moreover, with tanakan asthenia can be treated without polypragmasia.
Milopol'skaia
I M
IM
D000975:Antioxidants / Q000627:therapeutic use*; D001247:Asthenia / Q000188:drug therapy* / Q000209:etiology; D006259:Craniocerebral Trauma / Q000209:etiology; D020441:Ginkgo biloba; D006801:Humans; D009440:Neurasthenia / Q000150:complications; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D000096983:Ginkgo Extract
D000975:Antioxidants; D018696:Neuroprotective Agents; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract
Lechenie tanakanom astenicheskikh rasstroĭstv.